New insights into cardiogenic shock and coronary revascularization after acute myocardial infarction

Arch Cardiovasc Dis. 2020 Apr;113(4):276-284. doi: 10.1016/j.acvd.2019.12.005. Epub 2020 Feb 19.

Abstract

Cardiogenic shock complicating acute myocardial infarction is challenging, and continues to be associated with high rates of in-hospital and long-term mortality. Coronary revascularization is critical for improving prognosis in CS. Thus, a systematic protocol-driven approach to cardiogenic shock, the development of specialized cardiac care centres, technical advances in interventional cardiology enabling treatment of more complex and severe lesions, the availability of recent antithrombotic therapies and the evolution of new haemodynamic support devices are important considerations in current management of cardiogenic shock complicating acute ischaemic heart disease. Despite these potentially meaningful developments, several substantial gaps in knowledge still exist regarding optimal coronary revascularization of patients with cardiogenic shock. This review will describe current principles in the revascularization of these patients, with a focus on: the time to transfer and revascularize; the choice of vascular access site; the need for complete revascularization or only a culprit lesion strategy; the optimal antithrombotic therapy; the type, place and timing of haemodynamic support; and the medical care system network.

Keywords: Acute myocardial infarction; Cardiac shock centre; Cardiogenic shock; Choc cardiogénique; Coronary revascularization; Infarctus aigu du myocarde; Revascularisation coronaire; Réanimation cardiologique.

Publication types

  • Review

MeSH terms

  • Clinical Decision-Making
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / therapy*
  • Humans
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy*
  • Myocardial Revascularization* / adverse effects
  • Myocardial Revascularization* / mortality
  • Patient Selection
  • Recovery of Function
  • Risk Factors
  • Shock, Cardiogenic / diagnosis
  • Shock, Cardiogenic / mortality
  • Shock, Cardiogenic / physiopathology
  • Shock, Cardiogenic / therapy*
  • Treatment Outcome